Flebogamma DIF

human normal immunoglobulin · Instituto Grifols S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Flebogamma DIF, covering 2024-01-11 to 2024-01-11. Get the full timeline:

Most recent: EMA Authorised: Flebogamma DIF (previously Flebogammadif) (human normal immunoglobulin) — Instituto Grifols S.A.